Patient-Derived Xenografts

Patient-Derived Xenografts: Historical Evolution, Immunocompromised Host Models, and Translational Significance.-&nbsp;Patient-Derived Xenograft Models in Cancer Research: Methodology, Applications, and Future Prospects.- Patient-Derived Xenografts: A Valuable Preclinical Model for Drug Development and Biomarker Discovery.- Patient-Derived Xenograft Models for Leukemias.- Patient-Derived Orthotopic Xenograft Models for High-Grade Pediatric Brain Cancers.- Generation of Orthotopic and Subcutaneous Patient-Derived Xenograft Models from Diverse Clinical Tissue Samples of Pediatric Extracranial Solid Tumors.- Development of Orthotopic Patient-Derived Xenograft Models of Pediatric Intracranial Tumors.- A Humanized Patient-Derived Xenograft Model for Pancreatic Cancer.- Development and Expansion of Patient-Derived Xenografts for Endometrial Cancer.- A Multiplexed Approach to Assess Small Cell Lung Cancer Subtype Heterogeneity in Primary and Patient-Derived Tumor Samples.- Generation of Metastatic Cholangiocarcinoma Patient-Derived Xenograft Models.- Patient-Derived Xenograft Models for Translational Prostate Cancer Research and Drug Development.-&nbsp;Patient-Derived Xenograft Models for Ovarian Cancer.-&nbsp;Orthotopic MC-38 Allograft as a Robust Preclinical Model of Colorectal Carcinoma.- Assessing Protein Expression in Patient-Derived Xenografts Using Western Blotting.- Analysis of Protein Interactions in Patient-Derived Xenografts Using Immunoprecipitation.- A Semi-Automated Proteomics and Phosphoproteomics Protocol for the Identification of Novel Therapeutic Targets and Predictive Biomarkers in In Vivo Xenograft Models of Pediatric Cancers.<br>